Concepedia

Kiki Tahtis

KT

Statistics

Publications

6

Citations

341

H-Index

6

Active since

2001

Affiliations

Ludwig Cancer Research(Current)

Commonwealth Scientific and Industrial Research Organisation

Austin Hospital

National Cancer Institute

Kiki Tahtis is an author at Ludwig Cancer Research specializing in oncology, cancer immunotherapy, and molecular oncology.

Publications per year

2001–2008

6

Publications

6

Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration

Steven Suchting, Paul Heal, Kiki Tahtis et al. · The FASEB Journal · 2004 · 169 citations

Life Sciences, Cell Biology, Cell Signaling +14

Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.

Kiki Tahtis, F T Lee, Fiona E. Smyth et al. · PubMed · 2001 · 38 citations

Pharmacy, Oncology, Pharmacology +17

Radioimmunotherapy with α-Particle–Emitting 213Bi-C-Functionalized <i>trans</i>-Cyclohexyl-Diethylenetriaminepentaacetic Acid-Humanized 3S193 Is Enhanced by Combination with Paclitaxel Chemotherapy

Marcus P. Kelly, Fook T. Lee, Kiki Tahtis et al. · Clinical Cancer Research · 2007 · 36 citations

Medicine, Nuclear Medicine, Oncology +16

Tumor Targeting by a Multivalent Single-Chain Fv (scFv) Anti-Lewis Y Antibody Construct

Marcus P. Kelly, F.-T. Lee, Kiki Tahtis et al. · Cancer Biotherapy and Radiopharmaceuticals · 2008 · 34 citations

Pharmacy, Immunology, Oncology +17

Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.

Kiki Tahtis, Fook-Thean Lee, Jennifer M. Wheatley et al. · PubMed · 2003 · 34 citations

Medicine, Cell Biology, Oncology +17

1–5 of 6